Cantel Medical (CMN) Tops Q3 EPS by 8c

Cantel Medical (NYSE: CMN) reported Q3 EPS of $0.44, $0.08 better than the analyst estimate of $0.36. Revenue for the quarter came in at $173.7 million versus the consensus estimate of $163.16 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Citi raises Atlassian price target to $225, maintains Buy rating
• Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight